These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26374847)

  • 21. Deficiencies in the region syntenic to human 21q22.3 cause cognitive deficits in mice.
    Yu T; Clapcote SJ; Li Z; Liu C; Pao A; Bechard AR; Carattini-Rivera S; Matsui S; Roder JC; Baldini A; Mobley WC; Bradley A; Yu YE
    Mamm Genome; 2010 Jun; 21(5-6):258-67. PubMed ID: 20512340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.
    Sago H; Carlson EJ; Smith DJ; Rubin EM; Crnic LS; Huang TT; Epstein CJ
    Pediatr Res; 2000 Nov; 48(5):606-13. PubMed ID: 11044479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models.
    Souchet B; Duchon A; Gu Y; Dairou J; Chevalier C; Daubigney F; Nalesso V; Créau N; Yu Y; Janel N; Herault Y; Delabar JM
    Sci Rep; 2019 Mar; 9(1):3914. PubMed ID: 30850713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.
    Dowjat WK; Adayev T; Kuchna I; Nowicki K; Palminiello S; Hwang YW; Wegiel J
    Neurosci Lett; 2007 Feb; 413(1):77-81. PubMed ID: 17145134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a.
    Blazek JD; Abeysekera I; Li J; Roper RJ
    Hum Mol Genet; 2015 Oct; 24(20):5687-96. PubMed ID: 26206885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Context Fear Conditioning in Down Syndrome Mouse Models: Effects of Trisomic Gene Content, Age, Sex and Genetic Background.
    Ahmed MM; Block A; Busquet N; Gardiner KJ
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep Behavior and EEG Oscillations in Aged Dp(16)1Yey/+ Mice: A Down Syndrome Model.
    Levenga J; Peterson DJ; Cain P; Hoeffer CA
    Neuroscience; 2018 Apr; 376():117-126. PubMed ID: 29454635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage.
    Souchet B; Guedj F; Sahún I; Duchon A; Daubigney F; Badel A; Yanagawa Y; Barallobre MJ; Dierssen M; Yu E; Herault Y; Arbones M; Janel N; Créau N; Delabar JM
    Neurobiol Dis; 2014 Sep; 69():65-75. PubMed ID: 24801365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
    Olson LE; Richtsmeier JT; Leszl J; Reeves RH
    Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosage of the Abcg1-U2af1 region modifies locomotor and cognitive deficits observed in the Tc1 mouse model of Down syndrome.
    Marechal D; Lopes Pereira P; Duchon A; Herault Y
    PLoS One; 2015; 10(2):e0115302. PubMed ID: 25706610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
    Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
    Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Craniofacial dysmorphology in Down syndrome is caused by increased dosage of Dyrk1a and at least three other genes.
    Redhead Y; Gibbins D; Lana-Elola E; Watson-Scales S; Dobson L; Krause M; Liu KJ; Fisher EMC; Green JBA; Tybulewicz VLJ
    Development; 2023 Apr; 150(8):. PubMed ID: 37102702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of in vivo CA1 network activity in Dp(16)1Yey Down syndrome model mice.
    Raveau M; Polygalov D; Boehringer R; Amano K; Yamakawa K; McHugh TJ
    Elife; 2018 Feb; 7():. PubMed ID: 29485402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse models for Down syndrome-associated developmental cognitive disabilities.
    Liu C; Belichenko PV; Zhang L; Fu D; Kleschevnikov AM; Baldini A; Antonarakis SE; Mobley WC; Yu YE
    Dev Neurosci; 2011; 33(5):404-13. PubMed ID: 21865664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans.
    De la Torre R; De Sola S; Pons M; Duchon A; de Lagran MM; Farré M; Fitó M; Benejam B; Langohr K; Rodriguez J; Pujadas M; Bizot JC; Cuenca A; Janel N; Catuara S; Covas MI; Blehaut H; Herault Y; Delabar JM; Dierssen M
    Mol Nutr Food Res; 2014 Feb; 58(2):278-88. PubMed ID: 24039182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.
    Viard J; Loe-Mie Y; Daudin R; Khelfaoui M; Plancon C; Boland A; Tejedor F; Huganir RL; Kim E; Kinoshita M; Liu G; Haucke V; Moncion T; Yu E; Hindie V; Bléhaut H; Mircher C; Herault Y; Deleuze JF; Rain JC; Simonneau M; Lepagnol-Bestel AM
    Life Sci Alliance; 2022 Aug; 5(12):. PubMed ID: 35914814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.
    Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC
    J Comp Neurol; 2007 Oct; 504(4):329-45. PubMed ID: 17663443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic dissection of triplicated chromosome 21 orthologs yields varying skeletal traits in Down syndrome model mice.
    Sloan K; Thomas J; Blackwell M; Voisard D; Lana-Elola E; Watson-Scales S; Roper DL; Wallace JM; Fisher EMC; Tybulewicz VLJ; Roper RJ
    Dis Model Mech; 2023 Apr; 16(4):. PubMed ID: 36939025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between beta-amyloid production and tau phosphorylation in Alzheimer disease.
    Kimura R; Kamino K; Yamamoto M; Nuripa A; Kida T; Kazui H; Hashimoto R; Tanaka T; Kudo T; Yamagata H; Tabara Y; Miki T; Akatsu H; Kosaka K; Funakoshi E; Nishitomi K; Sakaguchi G; Kato A; Hattori H; Uema T; Takeda M
    Hum Mol Genet; 2007 Jan; 16(1):15-23. PubMed ID: 17135279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.